全文获取类型
收费全文 | 948312篇 |
免费 | 69252篇 |
国内免费 | 2953篇 |
专业分类
耳鼻咽喉 | 13180篇 |
儿科学 | 24614篇 |
妇产科学 | 23556篇 |
基础医学 | 134919篇 |
口腔科学 | 28628篇 |
临床医学 | 82925篇 |
内科学 | 185245篇 |
皮肤病学 | 19470篇 |
神经病学 | 73007篇 |
特种医学 | 37479篇 |
外国民族医学 | 93篇 |
外科学 | 154159篇 |
综合类 | 21328篇 |
一般理论 | 236篇 |
预防医学 | 62651篇 |
眼科学 | 21815篇 |
药学 | 74659篇 |
14篇 | |
中国医学 | 3121篇 |
肿瘤学 | 59418篇 |
出版年
2018年 | 9665篇 |
2017年 | 7671篇 |
2016年 | 8296篇 |
2015年 | 9752篇 |
2014年 | 13233篇 |
2013年 | 18505篇 |
2012年 | 25722篇 |
2011年 | 26698篇 |
2010年 | 15817篇 |
2009年 | 15080篇 |
2008年 | 25795篇 |
2007年 | 26837篇 |
2006年 | 27634篇 |
2005年 | 26701篇 |
2004年 | 25295篇 |
2003年 | 24314篇 |
2002年 | 23765篇 |
2001年 | 55190篇 |
2000年 | 57084篇 |
1999年 | 47425篇 |
1998年 | 10698篇 |
1997年 | 9412篇 |
1996年 | 9461篇 |
1995年 | 9210篇 |
1994年 | 8505篇 |
1993年 | 7752篇 |
1992年 | 35733篇 |
1991年 | 34139篇 |
1990年 | 32954篇 |
1989年 | 32082篇 |
1988年 | 29155篇 |
1987年 | 28388篇 |
1986年 | 26410篇 |
1985年 | 25285篇 |
1984年 | 17867篇 |
1983年 | 15167篇 |
1982年 | 7779篇 |
1981年 | 6767篇 |
1979年 | 15774篇 |
1978年 | 10592篇 |
1977年 | 9034篇 |
1976年 | 7867篇 |
1975年 | 8623篇 |
1974年 | 10473篇 |
1973年 | 9862篇 |
1972年 | 9370篇 |
1971年 | 8857篇 |
1970年 | 8424篇 |
1969年 | 7929篇 |
1968年 | 7206篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Malou A.H. Nuijten Thijs M.H. Eijsvogels Valerie M. Monpellier Ignace M.C. Janssen Eric J. Hazebroek Maria T.E. Hopman 《Obesity reviews》2022,23(1):e13370
Postbariatric loss of muscle tissue could negatively affect long-term health due to its role in various bodily processes, such as metabolism and functional capacity. This meta-analysis aimed to unravel time-dependent changes in the magnitude and progress of lean body mass (LBM), fat-free mass (FFM), and skeletal muscle mass (SMM) loss following bariatric surgery. A systematic literature search was conducted in Pubmed, Embase, and Web of Science. Fifty-nine studies assessed LBM (n = 37), FFM (n = 20), or SMM (n = 3) preoperatively and ≥1 time points postsurgery. Random-effects meta-analyses were performed to determine pooled loss per outcome parameter and follow-up time point. At 12-month postsurgery, pooled LBM loss was ?8.13 kg [95%CI ?9.01; ?7.26]. FFM loss and SMM loss were ?8.23 kg [95%CI ?10.74; ?5.73] and ?3.18 kg [95%CI ?5.64; ?0.71], respectively. About 55% of 12-month LBM loss occurred within 3-month postsurgery, followed by a more gradual decrease up to 12 months. Similar patterns were seen for FFM and SMM. In conclusion, >8 kg of LBM and FFM loss was observed within 1-year postsurgery. LBM, FFM, and SMM were predominantly lost within 3-month postsurgery, highlighting that interventions to mitigate such losses should be implemented perioperatively. 相似文献
4.
S. Harrogate J. Barnes K. Thomas A. Isted G. Kunst S. Gupta S. Rudd T. Banerjee R. Hinchliffe R. Mouton 《Anaesthesia》2023,78(11):1393-1408
Tobacco smoking is associated with a substantially increased risk of postoperative complications. The peri-operative period offers a unique opportunity to support patients to stop tobacco smoking, avoid complications and improve long-term health. This systematic review provides an up-to-date summary of the evidence for tobacco cessation interventions in surgical patients. We conducted a systematic search of randomised controlled trials of tobacco cessation interventions in the peri-operative period. Quantitative synthesis of the abstinence outcomes data was by random-effects meta-analysis. The primary outcome of the meta-analysis was abstinence at the time of surgery, and the secondary outcome was abstinence at 12 months. Thirty-eight studies are included in the review (7310 randomised participants) and 26 studies are included in the meta-analysis (5969 randomised participants). Studies were pooled for subgroup analysis in two ways: by the timing of intervention delivery within the peri-operative period and by the intensity of the intervention protocol. We judged the quality of evidence as moderate, reflecting the degree of heterogeneity and the high risk of bias. Overall, peri-operative tobacco cessation interventions increased successful abstinence both at the time of surgery, risk ratio (95%CI) 1.48 (1.20–1.83), number needed to treat 7; and 12 months after surgery, risk ratio (95%CI) 1.62 (1.29–2.03), number needed to treat 9. More work is needed to inform the design and optimal delivery of interventions that are acceptable to patients and that can be incorporated into contemporary elective and urgent surgical pathways. Future trials should use standardised outcome measures. 相似文献
5.
Li Dong Mari Nygård Nathalie C. Støer Ole Klungsøyr Bo T. Hansen 《International journal of cancer. Journal international du cancer》2023,153(2):399-406
Human papillomavirus (HPV) vaccine effectiveness may differ between settings. Here we present the first real-world effectiveness study of HPV vaccination on high-grade cervical lesions from Norway, among women who received HPV vaccine outside the routine program. We performed an observational study of all Norwegian women born 1975 to 1996 and retrieved individual data from nationwide registries on HPV vaccination status and incidence of histologically verified high-grade cervical neoplasia during 2006 to 2016. We estimated the incidence rate ratio (IRR) and 95% confidence intervals (CI) for vaccination vs no vaccination by Poisson regression stratified by age at vaccination <20 years and ≥20 years. The cohort consisted of 832 732 women, of which 46 381 (5.6%) received at least one dose of HPV vaccine by the end of 2016. The incidence rate of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) increased with age regardless of vaccination status and was highest at age 25 to 29, at 637/100 000 among unvaccinated women, 487/100 000 among women vaccinated before age 20 and 831/100 000 among women vaccinated at age 20 or older. The adjusted IRR of CIN2+ between vaccinated and unvaccinated women was 0.62 (95% CI: 0.46-0.84) for women vaccinated below age 20, and 1.22 (95% CI: 1.03-1.43) for women vaccinated at age 20 or older. These findings indicate that HPV vaccination among women too old to be eligible for routine HPV vaccination is effective among women who are vaccinated below age 20 but may not have the desired impact among women who are vaccinated at age 20 or older. 相似文献
6.
7.
8.
目的探讨脊髓小脑共济失调2型(SCA2)致病基因ATXN2异常等位基因中间重复个体的表型和分子遗传学特点。方法针对2005—2018年中日友好医院神经科运动障碍与神经遗传病研究中心收集的1383个常染色体显性遗传共济失调家系的先证者和部分家系成员,采用荧光标记毛细管电泳片段分析方法进行动态突变检测,对携带ATXN2基因中间重复的个体进行临床表型和遗传特征分析。结果共检出163个家系(包含先证者和家系成员共203人)携带异常扩展的ATXN2基因CAG重复序列,其中93个家系中有107例的异常扩展等位基因重复次数在29~34次之间。在其中的20个亲子对中,父系遗传16个,异常等位基因的代间扩展增加0~28次,母系遗传4个,异常等位基因的代间扩展增加0~4次。结论对于临床拟诊SCA2家系患者,需对其亲代或成年子代个体进行ATXN2基因检测,以免漏诊。动态突变基因检测有助于识别中间重复的个体,对明确家系致病基因和遗传咨询至关重要。 相似文献
9.
肥胖是世界上较为普遍的慢性病,不仅是糖尿病、心血管疾病和非酒精性脂肪肝等多种疾病的危险因素,还是感染性疾病的易感因素。西药在治疗肥胖上疗效明显,但是不良反应也显而易见。中药复方在肥胖等慢性代谢性疾病的临床疗效上具有突出的优势。然而,中药复方的减肥机制仍不清楚。因此,本文对近年来有关中药复方减肥的文献进行了综述和分析,重点对中药复方治疗肥胖症的机理进行了总结分析,以期为新药配伍的实验设计提供一些新的思路和方法。 相似文献
10.
Paulmurugan Ramasamy Malhotra Meenakshi Massoud Zahra T. Massoud Tarik F. 《Journal of molecular medicine (Berlin, Germany)》2022,100(7):1093-1093
Journal of Molecular Medicine - 相似文献